Log In
Print
BCIQ
Print
Print this Print this
 

ICT-121

  Manage Alerts
Collapse Summary General Information
Company ImmunoCellular Therapeutics Ltd.
DescriptionCancer stem cell vaccine that stimulates a cytotoxic T lymphocyte (CTL) response to CD133
Molecular Target Prominin 1 (PROM1) (CD133)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today